CSGEF yields 5.62% · MRK yields 2.76%● Live data
📍 CSGEF pulled ahead of the other in Year 1
Combined, CSGEF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSGEF + MRK for your $10,000?
China Suntien Green Energy Corporation Limited, together with its subsidiaries, develops and utilizes clean energy in Mainland China. It operates through three segments: Natural Gas, Wind Power and Solar Energy, and Other. The Natural Gas segment sells natural gas and gas appliances, as well as provides construction and connection services for natural gas pipelines. The Wind/Solar Power segment engages in the development, management, and operation of the wind farm and solar power plants; and generates and sells electric power for power grid companies. The Other segment engages in the management and property leasing business. As of December 31, 2021, the company owned 7 long-distance natural gas transmission pipelines, 20 high-pressure branch pipelines, 31 urban gas projects, 25 distribution stations, 19 gate stations, 6 compressed natural gas (CNG) primary filling stations, 3 CNG secondary filling stations, 3 liquefied natural gas filling station, and 2 L-CNG joint filling stations. It also had a wind power consolidated installed capacity of 5,673.85 megawatts (MW) and installed capacity under management of 5,869.45 MW, as well as an attributable installed capacity of 5,311.60 MW. It also engages in the provision of project investment, investment management, and technical development services; and investment and sale of solar energy appliances, as well as provides service consultancy services. Further, it offers operation and maintenance of photovoltaic power stations and logistics, loading and unloading, and transportation services. The company was incorporated in 2010 and is headquartered in Shijiazhuang, the People's Republic of China.
Full CSGEF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.